|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn646750655 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
071128s2008 nyua ob 001 0 eng d |
010 |
|
|
|z 2007048891
|
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d DKU
|d OCLCQ
|d FVL
|d YDXCP
|d OCLCQ
|d OCLCF
|d NLGGC
|d OCLCO
|d N$T
|d AU@
|d OCLCQ
|d AZK
|d LOA
|d OCLCO
|d OCLCA
|d COCUF
|d MOR
|d CCO
|d PIFAG
|d ZCU
|d OCLCO
|d OTZ
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d OCLCA
|d KIJ
|d OCLCO
|d STF
|d WRM
|d NRAMU
|d ICG
|d NLE
|d VT2
|d OCLCQ
|d UKMGB
|d YDX
|d DKC
|d OCLCQ
|d OCLCO
|d HS0
|d OCLCA
|d VLY
|d K6U
|d OCLCO
|d OCLCQ
|d OCL
|d SFB
|d OCLCQ
|d OCLCO
|d OCLCL
|
015 |
|
|
|a GBB7B1111
|2 bnb
|
016 |
7 |
|
|a 018394029
|2 Uk
|
019 |
|
|
|a 495790423
|a 722669081
|a 728036183
|a 780330574
|a 888955388
|a 961525890
|a 962723646
|a 966109820
|a 988516193
|a 991939010
|a 994915406
|a 1037718217
|a 1038575630
|a 1045512535
|a 1055345847
|a 1064097769
|a 1081223437
|a 1162120357
|
020 |
|
|
|a 9781420020304
|q (electronic bk.)
|
020 |
|
|
|a 1420020307
|q (electronic bk.)
|
020 |
|
|
|z 1420020307
|
020 |
|
|
|z 9780849390166
|
020 |
|
|
|z 0849390168
|
020 |
|
|
|a 0429116330
|
020 |
|
|
|a 9780429116339
|
029 |
1 |
|
|a AU@
|b 000048635409
|
029 |
1 |
|
|a AU@
|b 000053259871
|
029 |
1 |
|
|a DEBBG
|b BV044177873
|
029 |
1 |
|
|a NZ1
|b 13518319
|
029 |
1 |
|
|a UKMGB
|b 018394029
|
035 |
|
|
|a (OCoLC)646750655
|z (OCoLC)495790423
|z (OCoLC)722669081
|z (OCoLC)728036183
|z (OCoLC)780330574
|z (OCoLC)888955388
|z (OCoLC)961525890
|z (OCoLC)962723646
|z (OCoLC)966109820
|z (OCoLC)988516193
|z (OCoLC)991939010
|z (OCoLC)994915406
|z (OCoLC)1037718217
|z (OCoLC)1038575630
|z (OCoLC)1045512535
|z (OCoLC)1055345847
|z (OCoLC)1064097769
|z (OCoLC)1081223437
|z (OCoLC)1162120357
|
037 |
|
|
|a TANDF_187273
|b Ingram Content Group
|
050 |
|
4 |
|a RS201.T2
|b P433 2008eb
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615
|2 21
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Pharmaceutical dosage forms :
|b tablets.
|n Volume 3,
|p Manufacture and process control /
|c edited by Larry L. Augsburger, Stephen W. Hoag.
|
246 |
3 |
0 |
|a Tablets
|
250 |
|
|
|a 3rd ed. /
|b edited by Larry 1. Augsburger, Stephen W. Hoag.
|
260 |
|
|
|a New York :
|b Informa Healthcare USA,
|c ©2008.
|
300 |
|
|
|a 1 online resource (xiv, 311 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Foreword; Preface; Contents; Contributors; Chapter 1. Tooling for Pharmaceutical Processing; Chapter 2. Tablet Press Instrumentation in the Research and Development Environment; Chapter 3. Pharmaceutical Manufacturing: Changes in Paradigms; Chapter 4. A Forward-Looking Approach to Process Scale-Up for Solid Dose Manufacturing; Chapter 5. Dissolution and Drug Release Testing; Chapter 6. Setting Dissolution Specifications; Chapter 7. Mechanical Strength of Tablets; Chapter 8. cGMPs for the 21st Century and ICH Quality Initiatives
|
505 |
8 |
|
|a Chapter 9. Intellectual Property, Patent, and Patenting Process in the Pharmaceutical IndustryChapter 10. Near-infrared Chemical Imaging for Characterizing Pharmaceutical Dosage Forms; Chapter 11. Surface Area, Porosity, and Related Physical Characteristics; Back Cover
|
520 |
|
|
|a The ultimate goal of drug product development is to design a system that maximizes the therapeutic potential of the drug substance and facilitates its access to patients. Pharmaceutical Dosage Forms: Tablets, Third Edition is a comprehensive treatment of the design, formulation, manufacture, and evaluation of the tablet dosage form. With over 700 illustrations, it guides pharmaceutical scientists and engineers through difficult and technical procedures in a simple easy-to-follow format.New to the Third Edition:developments in formulation science and technologychanges in product regulationstrea.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Tablets (Medicine)
|
650 |
|
0 |
|a Drugs
|x Dosage forms.
|
650 |
|
0 |
|a Drugs
|x Design.
|
650 |
|
0 |
|a Quality control.
|
650 |
|
2 |
|a Tablets
|x pharmacology
|
650 |
|
2 |
|a Drug Compounding
|
650 |
|
2 |
|a Drug Design
|
650 |
|
2 |
|a Drug Industry
|x legislation & jurisprudence
|
650 |
|
2 |
|a Quality Control
|
650 |
|
2 |
|a Tablets
|
650 |
|
2 |
|a Dosage Forms
|
650 |
|
6 |
|a Comprimés.
|
650 |
|
6 |
|a Médicaments
|x Formes pharmaceutiques.
|
650 |
|
6 |
|a Médicaments
|x Conception.
|
650 |
|
6 |
|a Qualité
|x Contrôle.
|
650 |
|
7 |
|a quality control.
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Quality control
|2 fast
|
650 |
|
7 |
|a Drugs
|x Design
|2 fast
|
650 |
|
7 |
|a Drugs
|x Dosage forms
|2 fast
|
650 |
|
7 |
|a Tablets (Medicine)
|2 fast
|
700 |
1 |
|
|a Augsburger, Larry L.
|
700 |
1 |
|
|a Hoag, Stephen W.
|
758 |
|
|
|i has work:
|a v.3 Manufacture and process control Pharmaceutical dosage forms (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCXKDCJv6XGQH8P4pbrw483
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Pharmaceutical dosage forms.
|b 3rd ed.
|d New York : Informa Healthcare USA, ©2008
|w (DLC) 2007048891
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1405528
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 15918856
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10231563
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 961309
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2881464
|
994 |
|
|
|a 92
|b IZTAP
|